-
What I wish I knew sooner: highlighting gaps in early career researcher training
There is a clear need for additional training at all levels, but uncertainty remains as to how to deliver it all in a fair and systematic way.
-
Career considerations during lockdown
Use this time to think about your career trajectory and what aspects of your work are important to you.
-
The financial cost of doing science
In light of the current pandemic, it's worthwhile to consider the importance of both public and private investment in basic research programs and the growing role of science in our society.
-
Coronavirus and cancelled travel – some fringe benefits for researchers?
We have an incredible opportunity to explore some new virtual conferencing solutions, and have team leaders be more present in their labs than usual.
-
Lessons learned for hiring new staff at a startup
While every organization is different, sharing best practices can help inform process development.
-
Retroactive pension as a postdoc? Apply now!
It is sad that highly-qualified, highly-educated scientific researchers need to worry about pleading their case to have a national pension contribution.
-
Resiliency in science: We need to stop punishing vulnerability
The scientific profession is not for everyone, but there is no reason why we should actively be forcing people out.
-
On basic and applied science – and red herrings
Whatever we call it, investment in research will lead the way to important short- and long-term discoveries.
-
Limiting grants to well-funded labs
While no one is arguing for funding failure, the challenge is how we define “success.”
-
Who gets to see papers under review?
David Kent looks at whether it is ethical (and legal) for an academic to share a paper they are reviewing with their lab group.
-
The implication of the Hatch-Waxman Act for universities
Among the most interesting implications is the recognition that universities are not exempt from patent infringement for basic research.
-
Is NSERC turning the ship around?
I can happily report that something has indeed changed at NSERC and the number of postdoctoral fellowships being awarded is definitely recovering.
-
How the Hatch-Waxman Act of 1984 protects startups
This U.S. act allows biotech startups to use patented technology for the purposes of generating data for FDA approval without needing to take out costly licenses.
-
The challenges of crowdfunding academics
Kevin Leland created Halo, a curated fundraising platform for medical research, so that promising discoveries had a fighting chance to make it across the valley.
